Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Omidenepag Isopropyl bulk supplier for pharma manufacturers

Omidenepag Isopropyl 0.002% Suppliers & Bulk Manufacturers

Available Forms: Eye Drops

Available Strengths: 0.002%

Reference Brands: Eybelis

Category: Opthalmology

Omidenepag Isopropyl is a Opthalmology product available as Eye Drops in strengths 0.002%. It corresponds to the reference brand Eybelis. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Omidenepag isopropyl ophthalmic solution 0.002% (EYBELIS®) is a selective prostaglandin E2 receptor subtype 2 (EP2) agonist with a unique non-prostaglandin chemical structure. It has been developed for the treatment of glaucoma and ocular hypertension, conditions characterized by elevated intraocular pressure that can lead to progressive optic nerve damage and vision loss if left untreated. The product is the result of a collaborative development effort between Ube Industries and Santen Pharmaceutical.

Unlike conventional prostaglandin analogs, omidenepag isopropyl acts selectively on the EP2 receptor, promoting increased aqueous humor outflow through both trabecular and uveoscleral pathways. This distinct mechanism of action offers effective intraocular pressure reduction while providing a differentiated therapeutic profile. Omidenepag isopropyl is administered as a once-daily ophthalmic solution, supporting patient compliance in long-term glaucoma management.

Based on positive outcomes from phase III clinical trials demonstrating its efficacy and safety, omidenepag isopropyl ophthalmic solution 0.002% received regulatory approval in Japan in September 2018. This approval marked the first global authorization for this novel EP2 receptor agonist in glaucoma and ocular hypertension treatment, representing an important advancement in ophthalmic therapeutic options.

Omidenepag Isopropyl — third party manufacturing & bulk supply

Omidenepag Isopropyl 0.002% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Omidenepag Isopropyl listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Omidenepag Isopropyl →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Omidenepag isopropyl is used to lower elevated intraocular pressure in patients with glaucoma or ocular hypertension.

Omidenepag isopropyl is a synthetic small-molecule prodrug that is converted in ocular tissues to its active form, omidenepag.

The trade name of omidenepag isopropyl is Eybelis.

Omidenepag isopropyl is developed and marketed by Santen Pharmaceutical Co., Ltd.

The generic name of Omidenepag Isopropyl is omidenepag isopropyl.

The brand name of Omidenepag Isopropyl is Eybelis.

Omidenepag isopropyl is manufactured in Japan at GMP-compliant pharmaceutical facilities, primarily for the Japanese market.

Related Products

Artificial Tears

Strength:
0.3% to 1%

Form: Eye Drops/ Eye Gel/ Eye ointment

Reference Brands: Refresh Tears (USA/LATAM), Hylo-Tear (EU), Refresh Liquigel (India)

View Details
Tetrahydrozoline Hydrochloride

Strength:
0.05%

Form: Eye Drops

Reference Brands: Visine (USA/EU / LATAM), Ocuvis (India)

View Details
Faricimab

Strength:
6 mg/0.05 mL

Form: Injection

Reference Brands: Vabysmo (USA/EU)

View Details
Ranibizumab

Strength:
10 mg/mL

Form: Injection

Reference Brands: Lucentis (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.